While bodybuilders typically aim for 1.6-2.2 grams of protein per kilogram of body weight, being at the higher end of this range makes sense during retatrutide use
Cagrilintide is a synthetic, long-acting amylin analogue developed by Novo Nordisk
For clinicians, GLP-1based therapy has joined the toolkit for obesity in a way that demands attention and responsible use
Useful questions include: Approval status: is the drug approved or still investigational
DiMarchi, who was a vice president at Eli Lilly and involved in GLP-1 research there, until he left the company in 2003, is that many diseases may share the same root causes, even though we label them and treat them as distinct: This is an endocrine disease, this is a cardiovascular disease, this is a brain disease. This root-cause theory suggests that a wide range of conditions can be treatable with one drug class, sometimes through pathways in the brain and the immune system
You deserve a plan that works for your body and your life